Research associate
Location: NetherlandsSIRE Life Sciences® is the market leader in life science recruitment. We believe the recruitment market needs to gear up in technology and continues innovation. We like technology, in a life science market driven on science, we couldn’t stay behind; we drive Recruitment Science. Investing a majority of our turnover in technology enables us to use unique Resource Technologies. By using highly advanced algorithms, we enable our team of Resource & Data Strategists© to maintain the most advanced, detailed and complete Life Sciences network in Europe. This big data enables us to work Reverse Recruitment©: we first analyze the market in-depth before we go out to the market. Because we analyze the whole market, we can compare facts and data. This enables us to do Facts & Big Data Recruitment©, making sure we, or better yet, you find the right career!
THE COMPANY
Our client is a professional Biotechnology organization, based in Netherlands.
You will be involved in the development of antibodies through a broad set of in vitro experiments to study the anti-tumor activity and its inner workings.
ROLE DESCRIPTION
You get to work in the project team consisting of scientists and technicians that focuses on the discovery and development of therapeutic antibody products.
RESPONSIBILITIES
- perform experiments in the fields of immunology, tumor biology, protein biochemistry and cell and molecular biology
- documentation and processing of test results, interpretation and report to the team
- selection of clinical candidates by investigating the antibodies' mechanism of action
REQUIREMENTS
- completed HLO education or equivalent
- recent working experience in immunology and cell biology (cell culture, flow cytometry, ELISA, and functional cellular assays)
- additional knowledge of molecular biology and protein biochemistry is preferable
- fluent in both English and Dutch
Are you interested and do want to apply for this role, please fill out your application via the apply button below and contact Alexander Wielemaker.
